查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825967

2025年流感诊断全球市场报告

Influenza Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，流感诊断市场规模稳定成长，从2024年的27.3亿美元增加至2025年的28.7亿美元，复合年增长率为4.9%。历史时期的成长归因于电子商务的成长、劳动力短缺、自动化和生产力的提高、供应链优化、人事费用的上升以及政府对自动化和机器人技术的支持。

预计未来几年流感诊断市场规模将强劲成长，2029年将达到39亿美元，复合年增长率为8.0%。预测期内的成长可归因于客製化和可扩展性、环境和永续性目标、提高营运效率的需求以及满足现代供应链动态需求的需求。预测期内的主要趋势包括先进技术的整合、机器人拣选和包装、自主移动机器人、即时数据和分析、人工智慧主导的决策、协作机器人以及机器人技术的进步。

流感诊断，通常称为流感，包括各种检测流感病毒的测试。这些诊断方法包括病毒培养、血清学检测、快速抗原检测、逆转录聚合酵素链锁反应(RT-PCR)、萤光检测和快速分子检测。流感主要由三种流感病毒引起：甲型、乙型和丙型，其症状通常包括发烧、喉咙痛、咳嗽、身体疼痛、疲倦和头痛。流感诊断市场的收益来自进行流感病毒检测的营业单位。

传统的流感诊断检测包括快速输注检测 (RIDT)、病毒培养、DFA、血清学检测和其他检测。快速输注检测 (RIDT) 是免疫检测，可识别呼吸道检体中是否存在甲型和乙型流感病毒核蛋白抗原，并提供定性结果（阳性或阴性）。分子诊断检测包括多种方法，例如逆转录聚合酵素链锁反应(RT-PCR)、恒温核酸增幅试验 (INAAT)、环介导等温扩增试验、转录介导等温扩增试验和其他等恒温核酸增幅试验。这些检测方法被医院、临床实验室、诊断参考实验室、学术/研究机构和其他最终用户采用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供流感诊断市场统计数据，例如全球流感诊断行业市场规模、区域份额、竞争对手的流感诊断市场份额、详细的流感诊断市场细分、市场趋势和商业机会，以及您在流感诊断行业取得成功所需的数据。本流感诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切全面观点。

未来五年8.0%的预测成长率，较我们先前对该市场的预测略有下降0.5%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会增加韩国和德国供应的快速分子流感检测和多重聚合酵素链锁反应(PCR)系统的成本，从而减缓疫情应对速度并增加检测成本，对美国公共卫生构成重大挑战。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

快速诊断检测预计将推动流感诊断市场的成长。这些检测是旨在快速确认或排除病症和疾病的医疗工具，满足了医疗保健领域对准确及时结果日益增长的需求。快速流感诊断检测 (RIDT) 因其能够在 10-15 分钟内检测出流感病毒抗原并具有中等灵敏度（50-70%）而备受推崇。例如，澳洲健康与福利研究所 (Australian Institute of Health and Welfare) 在 2024 年 7 月报告称，影像诊断服务的数量从 2021-22 年的 2840 万增加到 2022-23 年的 2970 万。因此，快速诊断检测的广泛应用正在推动流感诊断市场的发展。

增加流感诊断研究的资金是推动市场成长的关键因素。要了解流感对公共卫生的影响，需要对病毒及其对个人和人群的影响进行全面的研究。加速对公共健康有重大影响的科学进步至关重要。公共和私人卫生组织、研究人员、医疗保健专业人员和生物製药公司正在增加对研究基金和津贴的投资，以降低疫情流感的风险。例如，2024年10月，澳洲政府透过卫生和老年护理部拨款9,500万美元用于禽流感应对措施，以保护农业、野生动物和经济。因此，增加研究资金正在推动流感诊断市场的发展。

流感诊断市场的参与企业正在积极创新和开发突破性产品，例如 Lucira COVID-19 和流感家用检测试剂盒，该产品可实现快速、同步的定性检测。这款一次性家用检测套组可让使用者在约 30 分钟内从自行采集的鼻拭子样本中获得结果。此类创新的一个例子是辉瑞 Lucira COVID-19 和流感家用检测试剂盒，该试剂盒于 2023 年 2 月获得美国製药公司辉瑞的核准。此检测试剂盒可同时检测甲型流感和乙型流感（俗称流感）以及导致 COVID-19 的 SARS-CoV-2 病毒。

快速流感诊断检测 (RIDT) 在流感诊断中的应用正日益广泛。 RIDT 是一种免疫检测，可识别呼吸道检体中是否存在甲型和乙型流感病毒核蛋白抗原，并提供定性结果（阳性或阴性）。这些检测可在约 15 分钟的临床相关时限内提供结果，尤其适用于诊断出流感样症状的患者，尤其是在症状出现后四天内。 RIDT 因其易于使用和快速诊断能力而日益普及。

2024年2月，印度医疗保健公司Thyrocare Technologies Limited收购了Think Health Diagnostic Private Limited，使其成为私人公司。此次收购扩展了Thyrocare的服务组合，扩大了客户推广，并增强了其在诊断领域的市场份额。除了血液诊断外，此次合併还引入了家庭心电图检测，将Thyrocare定位为提供体检前和年度健康检查的综合服务提供者。 Think Health Diagnostic 私人公司是一家总部位于印度的居家医疗保健服务公司，专门提供远端医疗、实验室检测和药房服务。

流感诊断市场的主要企业包括 F. Hoffmann-La Roche Ltd.、Quidel Corporation、Thermo Fisher Scientific Inc.、Abbott Laboratories、Hologic Inc.、Becton Dickinson and Company、DiaSorin SpA、Luminex Corporation、Meridian Bioscience Inc.、GenMark Diagnostics Inc.、SASiagnos LLC. Healthineers AG、Coris Bioconcept Sprl、Mast Group、Elitech Technology lnc.、Analytik Jena AG、altona Diagnostics GmbH、Tecan Trading AG、Genome Diagnostics Pvt Ltd.、Germaine Laboratories Inc.、Response Biomedical Corporation、TAUNS Laborator Inc. Inc.、TotalWellness Ltd.、Health Advocate Inc.、Optum Global Solutions Private Ltd. 等。

2024年，北美是流感诊断市场最大的地区。西欧是流感诊断市场的第二大地区。流感诊断市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美以及中东和非洲。

流感诊断市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙、加拿大

流感诊断市场包括检测套组、试剂和其他产品的收益。市场规模包括服务供应商销售或包含在其服务产品中的相关商品的价值。仅包括企业之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球流感诊断：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球流感诊断市场：成长率分析
  • 全球流感诊断市场表现：规模与成长，2019-2024
  • 全球流感诊断市场预测：2024-2029年、2034年规模与成长
  • 全球流感诊断：总目标市场（TAM）

第六章 市场细分

  • 全球流感诊断市场（按常规诊断测试、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 快速流感诊断测试（RIDT）
  • 病毒培养
  • 直接萤光抗体（DFA）检测
  • 血清学检测
  • 其他的
  • 全球流感诊断市场（按分子诊断测试）：2019-2024 年、2024-2029 年和 2034 年的表现和预测
  • 逆转录聚合酵素链锁反应（RT-PCR）
  • 恒温核酸增幅检测（INAAT）
  • 恒温环型核酸扩增试验
  • 转录介导的等温扩增试验
  • 其他等恒温核酸增幅试验
  • 其他分子诊断测试
  • 全球流感诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和临床实验室
  • 诊断参考实验室
  • 学术研究机构
  • 其他的
  • 全球流感诊断市场：快速流感诊断测试（RIDT）细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测测定测试
  • 横向流动化验
  • 酵素免疫分析法（EIA）
  • 全球流感诊断市场：病毒培养细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 细胞培养
  • 鸡蛋培养
  • 全球流感诊断市场：直接萤光抗体 (DFA) 测试细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接萤光抗体染色
  • 全球流感诊断市场：血清学检测细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 血凝抑制（HI）试验
  • 酵素免疫分析法（ELISA）
  • 西方印渍术试验
  • 全球流感诊断市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 萤光试验

第七章 区域和国家分析

  • 全球流感诊断市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球流感诊断市场（依国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 流感诊断市场：竞争格局
  • 流感诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Hologic Inc.

第31章：其他领先和创新企业

  • Becton Dickinson and Company
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • GenMark Diagnostics Inc.
  • SA Scientific Ltd.
  • Sekisui Diagnostics LLC
  • bioMerieux Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Coris Bioconcept Sprl
  • Mast Group
  • Elitech Technology Inc.
  • Analytik Jena AG
  • altona Diagnostics GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年流感诊断市场：提供新机会的国家
  • 2029年流感诊断市场：细分市场将带来新机会
  • 2029年流感诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32605u

The diagnosis of influenza, commonly known as the flu, involves employing various tests to detect the presence of the influenza virus. These diagnostic methods include viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza is caused by three primary types of the influenza virus such as type A, type B, and type C. Its symptoms typically include fever, sore throat, cough, body ache, fatigue, and headache. The market for influenza diagnostics encompasses the revenues generated by entities involved in conducting tests for the detection of the influenza virus.

The conventional diagnostic tests for influenza comprise rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays, and other tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays capable of identifying the presence of influenza A and B viral nucleoprotein antigens in respiratory samples, offering a qualitative outcome (positive or negative). Molecular diagnostic tests encompass a range of methods such as Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop-mediated isothermal-based amplification assays, transcription-mediated isothermal-based amplification assays, and other isothermal nucleic acid amplification tests. These tests are employed by hospitals, clinical laboratories, diagnostic reference laboratories, academic/research institutes, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides influenza diagnostic market statistics, including influenza diagnostic industry global market size, regional shares, competitors with a influenza diagnostic market share, detailed influenza diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. This influenza diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The influenza diagnostic market size has grown steadily in recent years. It will grow from $2.73 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to e-commerce growth, labor shortages, automation and productivity, supply chain optimization, rising costs of labor, government support for automation and robotics.

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.9 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to customization and scalability, environmental and sustainability goals, need to improve operational efficiency, need to meet the demands of modern supply chain dynamics. Major trends in the forecast period include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, ai-driven decision making, collaborative robots, advancements in robotic technology.

The forecast of 8.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. public health by increasing costs for rapid molecular influenza tests and multiplex Polymerase Chain Reaction(PCR) systems sourced from South Korea and Germany, potentially delaying outbreak responses and raising laboratory testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Rapid diagnostic tests are anticipated to drive the growth of the influenza diagnostic market. These tests are medical tools designed to quickly confirm or rule out a condition or disease, addressing the rising demand for accurate and timely results in healthcare. Rapid influenza diagnostic tests (RIDTs) are particularly valued for their ability to detect influenza viral antigens within 10-15 minutes, offering moderate sensitivity (50-70%). For example, in July 2024, the Australian Institute of Health and Welfare reported that diagnostic imaging services increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, the growing adoption of rapid diagnostic tests is propelling the influenza diagnostic market.

Increasing funding for research on influenza diagnostics is a key factor driving market growth. Understanding the public health impact of influenza requires comprehensive research into the virus and its effects on individuals and populations. Accelerating scientific advancements with significant public health implications is essential. Public and private health organizations, researchers, healthcare professionals, and biopharmaceutical companies have been increasing investments in research funding or grants to mitigate the risks of pandemic influenza. For example, in October 2024, the Australian Government, through the Department of Health and Aged Care, allocated $95 million to combat avian influenza, aimed at protecting agriculture, wildlife, and the economy. As a result, increasing research funding is propelling the influenza diagnostic market.

Key players in the influenza diagnostic market are actively innovating and developing groundbreaking products like the Lucira COVID-19 & Flu Home Test, allowing rapid simultaneous qualitative detection. This single-use at-home test kit enables users to obtain results from self-collected nasal swab samples in approximately 30 minutes. An example of such innovation is the approval received by Pfizer Inc., a US-based pharmaceutical company, in February 2023 for the Lucira by Pfizer COVID-19 & Flu Home Test. This test is capable of detecting both influenza A and B (commonly known as the flu) and SARS-CoV-2, the virus responsible for COVID-19.

The utilization of rapid influenza diagnostic tests (RIDTs) in influenza diagnostics is increasingly prevalent. RIDTs, which are immunoassays, identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, providing a qualitative result (positive or negative). These tests deliver outcomes within a clinically relevant timeframe of approximately 15 minutes and are particularly effective in diagnosing patients with influenza-like symptoms, especially within the first four days of symptom onset. The growing favor for RIDTs is attributed to their user-friendly nature and swift diagnostic capabilities.

In February 2024, Thyrocare Technologies Limited, an India-based healthcare company, acquired Think Health Diagnostic Private Limited for an undisclosed amount. The acquisition expands Thyrocare's service portfolio, enabling broader customer outreach and strengthening its market share in the diagnostic sector. This integration also introduces at-home ECG testing alongside blood diagnostics, establishing Thyrocare as a comprehensive provider for premedical and annual health checkups. Think Health Diagnostic Private Limited is an India-based home healthcare services company specializing in telehealth, laboratory testing, and pharmacy services.

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMerieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the influenza diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Influenza Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on influenza diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for influenza diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The influenza diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests
  • 2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
  • 3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
  • Subsegments:
  • 1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)
  • 2) By Viral Culture: Cell Culture; Egg-based Culture
  • 3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
  • 4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay
  • 5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Quidel Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Hologic Inc.; Becton Dickinson and Company; DiaSorin SpA; Luminex Corporation; Meridian Bioscience Inc.; GenMark Diagnostics Inc.; SA Scientific Ltd.; Sekisui Diagnostics LLC; bioMerieux Inc.; Danaher Corporation; Siemens Healthineers AG; Coris Bioconcept Sprl; Mast Group; Elitech Technology lnc.; Analytik Jena AG; altona Diagnostics GmbH; Tecan Trading AG; Genome Diagnostics Pvt Ltd.; Germaine Laboratories Inc.; Response Biomedical Corporation; TAUNS Laboratories Inc.; TRUPCR Europe Ltd.; Quest Diagnostics Inc.; Labcorp Employer Services Inc.; TotalWellness Ltd.; Health Advocate Inc.; Optum Global Solutions Private Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Influenza Diagnostic Market Characteristics

3. Influenza Diagnostic Market Trends And Strategies

4. Influenza Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Influenza Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Influenza Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Influenza Diagnostic Market Growth Rate Analysis
  • 5.4. Global Influenza Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Influenza Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Influenza Diagnostic Total Addressable Market (TAM)

6. Influenza Diagnostic Market Segmentation

  • 6.1. Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Influenza Diagnostic Tests (RIDT)
  • Viral Culture
  • DFA
  • Serological Assays
  • Other Traditional Diagnostic Tests
  • 6.2. Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • Isothermal Nucleic Acid Amplification Tests (INAAT)
  • Loop Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Other Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Diagnostic Tests
  • 6.3. Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Other End Users
  • 6.4. Global Influenza Diagnostic Market, Sub-Segmentation Of Rapid Influenza Diagnostic Tests (RIDT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay-based Tests
  • Lateral Flow Assays
  • Enzyme Immunoassays (EIA)
  • 6.5. Global Influenza Diagnostic Market, Sub-Segmentation Of Viral Culture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture
  • Egg-based Culture
  • 6.6. Global Influenza Diagnostic Market, Sub-Segmentation Of Direct Fluorescent Antibody (DFA) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Fluorescent Antibody Staining
  • 6.7. Global Influenza Diagnostic Market, Sub-Segmentation Of Serological Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemagglutination Inhibition (HI) Assay
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blotting Assay
  • 6.8. Global Influenza Diagnostic Market, Sub-Segmentation Of Other Traditional Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Immunofluorescence Assays

7. Influenza Diagnostic Market Regional And Country Analysis

  • 7.1. Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Influenza Diagnostic Market

  • 8.1. Asia-Pacific Influenza Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Influenza Diagnostic Market

  • 9.1. China Influenza Diagnostic Market Overview
  • 9.2. China Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Influenza Diagnostic Market

  • 10.1. India Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Influenza Diagnostic Market

  • 11.1. Japan Influenza Diagnostic Market Overview
  • 11.2. Japan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Influenza Diagnostic Market

  • 12.1. Australia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Influenza Diagnostic Market

  • 13.1. Indonesia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Influenza Diagnostic Market

  • 14.1. South Korea Influenza Diagnostic Market Overview
  • 14.2. South Korea Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Influenza Diagnostic Market

  • 15.1. Western Europe Influenza Diagnostic Market Overview
  • 15.2. Western Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Influenza Diagnostic Market

  • 16.1. UK Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Influenza Diagnostic Market

  • 17.1. Germany Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Influenza Diagnostic Market

  • 18.1. France Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Influenza Diagnostic Market

  • 19.1. Italy Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Influenza Diagnostic Market

  • 20.1. Spain Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Influenza Diagnostic Market

  • 21.1. Eastern Europe Influenza Diagnostic Market Overview
  • 21.2. Eastern Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Influenza Diagnostic Market

  • 22.1. Russia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Influenza Diagnostic Market

  • 23.1. North America Influenza Diagnostic Market Overview
  • 23.2. North America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Influenza Diagnostic Market

  • 24.1. USA Influenza Diagnostic Market Overview
  • 24.2. USA Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Influenza Diagnostic Market

  • 25.1. Canada Influenza Diagnostic Market Overview
  • 25.2. Canada Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Influenza Diagnostic Market

  • 26.1. South America Influenza Diagnostic Market Overview
  • 26.2. South America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Influenza Diagnostic Market

  • 27.1. Brazil Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Influenza Diagnostic Market

  • 28.1. Middle East Influenza Diagnostic Market Overview
  • 28.2. Middle East Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Influenza Diagnostic Market

  • 29.1. Africa Influenza Diagnostic Market Overview
  • 29.2. Africa Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Influenza Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Influenza Diagnostic Market Competitive Landscape
  • 30.2. Influenza Diagnostic Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Influenza Diagnostic Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. DiaSorin SpA
  • 31.3. Luminex Corporation
  • 31.4. Meridian Bioscience Inc.
  • 31.5. GenMark Diagnostics Inc.
  • 31.6. SA Scientific Ltd.
  • 31.7. Sekisui Diagnostics LLC
  • 31.8. bioMerieux Inc.
  • 31.9. Danaher Corporation
  • 31.10. Siemens Healthineers AG
  • 31.11. Coris Bioconcept Sprl
  • 31.12. Mast Group
  • 31.13. Elitech Technology Inc.
  • 31.14. Analytik Jena AG
  • 31.15. altona Diagnostics GmbH

32. Global Influenza Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Influenza Diagnostic Market

34. Recent Developments In The Influenza Diagnostic Market

35. Influenza Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Influenza Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Influenza Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Influenza Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer